| Aquirian Limited (AQN) ORDINARY FULLY PAID |
Industrials |
$32 |
Appendix 4E and Annual Finance Report FY24
|
28 Aug 2024 8:10AM |
$0.175 |
$0.325 |
risen by
85.71%
|
|
AQN - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues from ordinary activities down 12.0% to $23,163,888
- EBITDA from ordinary activities down 24.6% to $2,697,688
- Profit from ordinary activities after tax down 218.7% to a loss of $648,999
- No dividends declared during or subsequent to the financial year
- Wubin Ammonium Nitrate Emulsion Facility acquired for $9.6 million
- Strategic exit from heavy equipment services business
- Key developments: continued development of Collar Keeper® System and acquisition of Wubin Emulsion Facility
- Positive cash flow from operating activities: $6,794,773
- Net tangible assets per security down from 9.43 cents to 7.89 cents
- Directors declare compliance with Australian Accounting Standards and Corporations Act 2001
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tabcorp Holdings Limited (TAH) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,635 |
Full Year Results - ASX Release
|
28 Aug 2024 8:10AM |
$0.565 |
$0.715 |
risen by
26.55%
|
|
TAH - Price-sensitive ASX Announcement
Full Release
Key Points
- Group revenue down 3.9% to $2,338.9 million.
- EBITDA decreased by 18.7% to $317.7 million.
- Statutory net loss after tax of $1,359.7 million.
- Digital wagering revenue down 2.2%, cash wagering revenue up 0.4%.
- Significant non-cash impairment charges totaling $1,376.4 million.
- New 20-year Victorian Wagering and Betting Licence awarded.
- Investments in customer safety capabilities increased.
- Strategic achievements include product launches and venue upgrades.
- Macroeconomic environment and regulatory conditions expected to remain challenging.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| The Market Limited (MKT) ORDINARY FULLY PAID |
Communication Services |
$43 |
A Year of Transformation
|
28 Aug 2024 8:09AM |
$0.140 |
$0.135 |
fallen by
3.57%
|
|
MKT - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue up 12% to $91.5m
- Reported EBITDA before impairment of $0.5m, adjusting for one-off costs underlying EBITDA at $7.8m
- Ongoing deleveraging with $8.0m repaid to CBA
- Significant one-off costs impacted FY24 results
- Gumtree Group launched Transactional offerings and announced a partnership with the Homely Group
- Capital Markets business invested in user experience improvements
- Two independent board members and an independent Chairman were appointed
- Future growth expectations for FY25 excluding one-off costs
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imricor Medical Systems Inc (IMR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$532 |
Imricor releases Half Year Results for 1H 2024
|
28 Aug 2024 8:09AM |
$0.520 |
$1.660 |
risen by
219.23%
|
|
IMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for 1H 2024 was $2.1 million, a decrease compared to $2.4 million for 1H 2023.
- Net loss for 1H 2024 was $7.3 million, compared to a net loss of $7.6 million for 1H 2023.
- Cash and cash equivalents were $2.6 million as of June 30, 2024.
- Company continues to focus on commercialization of its products and expanding its customer base.
- Notable progress in product development and regulatory approval processes.
- Operational highlights include successful completion of clinical trials and expansion of the product portfolio.
- Strategic initiatives include partnerships and collaborations to drive growth.
- Challenges remain in market adoption and regulatory hurdles.
- Company remains optimistic about future growth prospects despite current financial challenges.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| The Market Limited (MKT) ORDINARY FULLY PAID |
Communication Services |
$43 |
Preliminary Final Report
|
28 Aug 2024 8:09AM |
$0.140 |
$0.135 |
fallen by
3.57%
|
|
MKT - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue up 12% to $91.5m
- Reported EBITDA from continuing operations of ($1.7m)
- Underlying EBITDA from continuing operations at $7.8m
- Net losses attributable to owners of The Market Limited of $6.95m
- Gumtree Group achieves significant traffic with 5.5 million unique users monthly
- Ongoing deleveraging with $8.0m repaid to CBA
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Delorean Corporation Limited (DEL) ORDINARY FULLY PAID |
Utilities |
$39 |
First Build/Own/Operate Bioenergy Project Funding Secured
|
28 Aug 2024 8:09AM |
$0.080 |
$0.175 |
risen by
118.75%
|
|
DEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Delorean Corporation Limited has secured a $30 million corporate lending facility from Tanarra Restructuring Partners.
- The facility is divided into two tranches: $5 million for working capital and $25 million for funding the SA1 bioenergy project.
- The SA1 bioenergy plant in Adelaide will process 70,000 tonnes of organic waste annually, producing renewable natural gas.
- Delorean has also reached a settlement with Palisade Impact for the redemption of $5 million in convertible notes.
- The secured funding allows Delorean to commence its first build/own/operate bioenergy infrastructure project, with potential expansion to other projects.
- The financial close of the facility is expected in September 2024 with conditions precedent and definitive legal documentation to be completed.
- The SA1 project construction is expected to begin in Q4 2024 and be fully operational by Q1 2026.
- The VIC1 bioenergy plant in Victoria, 90% owned by Delorean, will process 54,000 tonnes of organic waste annually, generating 1.2MW of renewable electricity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Desert Metals Limited (DM1) ORDINARY FULLY PAID |
Materials |
$8 |
Multiple high-grade gold assays returned from Tengrela South
|
28 Aug 2024 8:09AM |
$0.025 |
$0.019 |
fallen by
24%
|
|
DM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Multiple high-grade gold intercepts returned from Tengrela South drilling in Côte d'Ivoire
- Desert Metals completed 14 reverse circulation drill holes at the Podio prospect
- Significant gold mineralisation intersected in 11 of the 14 drill holes
- Drilling results include 13m at 1.85g/t gold and 3m at 6.19g/t gold
- Potential Mineral Resource calculation planned for the Podio prospect
- Further exploration and drilling planned at Adzope in September 2024
- Encouraging results from lithium assays at the Logbog prospect
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Helix Resources Limited (HLX) ORDINARY FULLY PAID |
Materials |
$7 |
Investor Presentation
|
28 Aug 2024 8:08AM |
$0.004 |
$0.002 |
fallen by
50%
|
|
| Imricor Medical Systems Inc (IMR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$532 |
Appendix 4D and Half Year Report & Accounts
|
28 Aug 2024 8:08AM |
$0.520 |
$1.660 |
risen by
219.23%
|
|
IMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 104.9% to $407,756.
- Net loss of $6,858,199, a 25.6% reduction from previous period.
- Significant revenue driver was increased product sales.
- Primary product is the Vision-MR Ablation Catheter for MRI-guided cardiac procedures.
- Company focused on MRI-compatible products for cardiac procedures.
- Raised substantial funds through stock issuance.
- Auditor's review highlights doubt about the company’s ability to continue due to recurring losses.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Helix Resources Limited (HLX) ORDINARY FULLY PAID |
Materials |
$7 |
Muriel Tank Historical Goldfield
|
28 Aug 2024 8:08AM |
$0.004 |
$0.002 |
fallen by
50%
|
|
HLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Helix Resources Limited owns 100% of the Muriel Tank historical gold mining area.
- Muriel Tank has recorded production of over 400 tonnes at 15 g/t Au from shallow workings up to 30 meters deep.
- Gold mineralisation at Muriel Tank is hosted within shear zones up to 4 meters wide containing quartz veins and quartz breccias up to 2 meters thick.
- Historical exploration identified gold values in Tritton-style copper-gold deposits located nearby.
- Recent field mapping identified previously untested sub-parallel zones of blue quartz veins which are prospective for further gold mineralisation.
- Helix's exploration program includes continued geological mapping, surface sampling, and targeted drilling to expand the gold potential of Muriel Tank.
- Previous rock chip assays and drill hole assays may have underreported gold grades due to sub-sampling methods.
- Muriel Tank project benefits from proximity to existing gold processing infrastructure.
- Several historical mine shafts produced high-grade gold ore with significant intercepts from previous shallow RC drilling.
- Upcoming plans include detailed geological mapping, auger sampling, and drilling to define new targets and extensions of known veins.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DY6 Metals Ltd (DY6) ORDINARY FULLY PAID |
Materials |
$8 |
Completion of Ngala Hill recon sampling
|
28 Aug 2024 8:08AM |
$0.053 |
$0.130 |
risen by
145.28%
|
|
| Tabcorp Holdings Limited (TAH) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,635 |
Dividend/Distribution - TAH
|
28 Aug 2024 8:08AM |
$0.565 |
$0.715 |
risen by
26.55%
|
|
| Horizon Minerals Limited (HRZ) ORDINARY FULLY PAID |
Materials |
$103 |
Nimbus Zinc Silver Project Update
|
28 Aug 2024 8:08AM |
$0.042 |
$0.047 |
risen by
11.90%
|
|
HRZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Current global Mineral Resource estimate for Nimbus is 12.1Mt grading 52g/t Ag for 20.24Moz of silver and 0.9% Zn for 106kt zinc.
- A high-grade subset within the global resource has an estimate of 260kt grading 774g/t Ag for 6.4Moz silver and 12.8% Zn for 33kt zinc.
- Concept study confirms the optimal economic development through mining higher-grade lodes and producing a silver/zinc concentrate.
- Approval for a Programme of Work (POW) by DEMIRS with drilling expected in the first half of 2025.
- Nimbus was classified as a contaminated site in 2006 but cleanup was completed in 2022, and reclassification is pending.
- Historical mining phases and production between 2004-2007 yielded 3.6 Moz of silver from 318 kt of ore.
- Potential VMS (Zn – Ag – Pb) Exploration Target of 550,000-700,000 tonnes with grades of 3.4 – 3.6% Zn and 140 – 210g/t Ag.
- Environmental assessments and reclassifications have been conducted to facilitate future mining operations.
- An independent review highlighted the potential for underground mining and generating silver and zinc concentrates.
- The project has licenses and approvals in place for further mining and processing activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amotiv Limited (AOV) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,064 |
Notification of cessation of securities - AOV
|
28 Aug 2024 8:08AM |
$10.150 |
$7.800 |
fallen by
23.15%
|
|
| Tabcorp Holdings Limited (TAH) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,635 |
Appendix 4E and Annual Report
|
28 Aug 2024 8:07AM |
$0.565 |
$0.715 |
risen by
26.55%
|
|
TAH - Price-sensitive ASX Announcement
Full Release
Key Points
- Tabcorp Holdings Limited reported a statutory net profit after tax (NPAT) of $66.9 million for FY23.
- The company's revenue for FY23 was $2,430.0 million, an increase from the previous year.
- The earnings before interest and taxes (EBIT) for FY23 stood at $361.0 million.
- Tabcorp's wagering and media business experienced a revenue increase of 4.3% to $2,147.0 million.
- The gaming services business saw a decrease in revenue by 5.6% to $283.0 million.
- Operational highlights include successful integration of UBET and digital transformation initiatives.
- The company's board has declared a final dividend of 7.0 cents per share, fully franked.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amotiv Limited (AOV) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,064 |
Change of Director's Interest Notice
|
28 Aug 2024 8:07AM |
$10.150 |
$7.800 |
fallen by
23.15%
|
|
| Amotiv Limited (AOV) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,064 |
Notification regarding unquoted securities - AOV
|
28 Aug 2024 8:07AM |
$10.150 |
$7.800 |
fallen by
23.15%
|
|
| Fleetwood Limited (FWD) ORDINARY FULLY PAID |
Consumer Discretionary |
$261 |
Notification of cessation of securities - FWD
|
28 Aug 2024 8:07AM |
$1.670 |
$2.800 |
risen by
67.66%
|
|
| Aneka Tambang (Persero) Tbk (Pt) (ATM) CHESS DEPOSITARY INTERESTS 1:5 |
Materials |
$1 |
ANTAM Presents Latest Corporate Performance at Public Expose
|
28 Aug 2024 8:06AM |
$1.030 |
$0.900 |
fallen by
12.62%
|
|
| Piedmont Lithium Limited (PLL) CHESS DEPOSITARY INTERESTS 100:1 US PROHIBITED |
Materials |
$60 |
Sayona Mining Announces Increase to Mineral Resource for NAL
|
28 Aug 2024 8:06AM |
$0.130 |
$0.097 |
fallen by
25.38%
|
|
| EMvision Medical Devices Limited (EMV) ORDINARY FULLY PAID |
Health Care |
$150 |
Appendix 4G & Corporate Governance Statement
|
28 Aug 2024 8:06AM |
$2.100 |
$1.750 |
fallen by
16.67%
|
|
| Power Minerals Limited (PNN) ORDINARY FULLY PAID |
Materials |
$8 |
Further high-grade niobium, tantalum and REE at Lltio
|
28 Aug 2024 8:06AM |
$0.080 |
$0.060 |
fallen by
25%
|
|
PNN - Price-sensitive ASX Announcement
Full Release
Key Points
- Further high-grade niobium, tantalum and rare earth element (REE) results at Lltio Project in Brazil.
- Latest samples include high concentrations of niobium and tantalum.
- Sampling confirms high-grade niobium and tantalum mineralisation across the entire Lltio Project.
- A LiDAR survey will be conducted to identify new pegmatite dykes.
- Bulk sampling, trenching, and maiden drilling are planned as next phases of the project.
- Sampling is designed to evaluate and prioritise numerous pegmatites within the Lltio Project area.
- High-grade niobium (Nb2O5) and tantalum (Ta2O5) identified in multiple samples.
- Results are consistent with previous high-grade findings, providing strong validation of the exploration strategy.
- Next steps include more substantive exploration activities based on LiDAR survey results.
- Sample results show a significant presence of partial rare earth oxides (PREO).
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EMvision Medical Devices Limited (EMV) ORDINARY FULLY PAID |
Health Care |
$150 |
Appendix 4E & Annual Report to 30 June 2024
|
28 Aug 2024 8:06AM |
$2.100 |
$1.750 |
fallen by
16.67%
|
|
EMV - Price-sensitive ASX Announcement
Full Release
Key Points
- No dividends paid during the financial year ended 30 June 2024
- Loss for the company after income tax amounted to $2,729,610
- Revenue increased by 63% to $11,560,412
- Total grant income of $4,299,473 generated from the Australian Stroke Alliance and Modern Manufacturing Initiative Medical Products Manufacturing Translation Stream program
- R&D Tax Incentive rebate revenue of $6,846,483
- Operating expenses related to research and development, employee expenses, general corporate overheads, non-cash share-based payments, and depreciation
- Total administration, employee, and research costs of $12,191,955
- Net operating cash outflows were $5,991,708
- Net financing cash inflows for the year were $15,001,337
- Strategic $15,281,174 investment from Keysight Technologies Inc.
- Net asset position at 30 June 2024 of $18,515,748
- Completion of multi-site clinical trial with production equivalent emu™ device
- Pilot commercial production line established at Macquarie Park HQ
- Preparing for FDA meeting to finalize protocol for upcoming Validation trial
- Unveiling of First Responder proof of concept unit
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Noviqtech Limited (NVQ) ORDINARY FULLY PAID |
Information Technology |
$7 |
Cleansing Notice
|
28 Aug 2024 8:06AM |
$0.023 |
$0.026 |
risen by
13.04%
|
|
| Noviqtech Limited (NVQ) ORDINARY FULLY PAID |
Information Technology |
$7 |
Application for quotation of securities - NVQ
|
28 Aug 2024 8:06AM |
$0.023 |
$0.026 |
risen by
13.04%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
